United Therapeutics Corporation
United Therapeutics Corporation/ US91307C1027 /
UTHR
2024-04-22 10:00:00 PM
|
Chg.
-3.8700
|
Volume |
Bid11:10:36 PM |
Ask11:10:36 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
234.0600USD
|
-1.63%
|
552,493 Turnover: 91.06 mill. |
212.0100Bid Size: 100 |
243.0100Ask Size: 100 |
11.01 bill.USD |
- |
11.12 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
21.04 USD |
31.66% |
EPS Diluted: |
19.81 USD |
32.07% |
Revenues per Share: |
49.46 USD |
18.27% |
Book Value per Share: |
127.18 USD |
22.76% |
Cash Flow per Share: |
20.78 USD |
19.91% |
Dividend per Share: |
- USD |
- |
Total |
in mill. |
|
Revenues: |
2,327.50 USD |
20.20% |
Net Income: |
984.80 USD |
35.40% |
Operating Cash Flow: |
978.00 USD |
- |
Cash and Cash Equivalents: |
1,207.70 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
11.12 |
10.45 |
P/S Ratio: |
4.73 |
4.45 |
P/BV ratio: |
1.84 |
1.73 |
P/CF Ratio: |
11.26 |
10.58 |
PEG: |
0.35 |
0.33 |
Earnings Yield: |
8.99% |
9.57% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
11.01 bill. USD |
10.35 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
47.06 mill. |
|
Profitability
Gross Profit Margin: |
88.94% |
EBIT Margin: |
50.91% |
Net Profit Margin: |
42.31% |
Return on Equity: |
16.46% |
Return on Assets: |
13.74% |
Financial Strength
Liquidity I / Cash Ratio: |
150.14% |
Liquidity II / Quick Ratio: |
184.81% |
Liquidity III / Current Ratio: |
441.45% |
Debt / Equity Ratio: |
19.75% |
Dynam. Debt / Equity Ratio: |
120.88% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
2023-12-31 |
Accounting Standard: |
US GAAP |